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Abstract
Background: Simultaneous carriage of more than one strain of Streptococcus pneumoniae promotes horizontal gene
transfer events and may lead to capsule switch and acquisition of antibiotic resistance. We studied the epidemiology of
cocolonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal vaccine
(PCV7).
Methodology: Nasopharyngeal swabs (n 1120) were collected from outpatients between 2004 and 2009 within an ongoing
nationwide surveillance program. Cocolonization was detected directly from swabs by restriction fragment length
polymorphism (RFLP) analysis. Serotypes were identified by agglutination, multiplex PCR and microarray.
Principal Findings: Rate of multiple colonization remained stable up to three years after PCV7 introduction. Cocolonization
was associated with serotypes of low carriage prevalence in the prevaccine era. Pneumococcal colonization density was
higher in cocolonized samples and cocolonizing strains were present in a balanced ratio (median 1.38). Other characteristics
of cocolonization were a higher frequency at young age, but no association with recurrent acute otitis media, recent
antibiotic exposure, day care usage and PCV7 vaccination status.
Conclusions: Pneumococcal cocolonization is dominated by serotypes of low carriage prevalence in the prevaccine era,
which coexist in the nasopharynx. Emergence of such previously rare serotypes under vaccine selection pressure may
promote cocolonization in the future.
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Introduction
The epidemiology of Streptococcus pneumoniae is changing since the
introduction of the seven-valent conjugated pneumococcal poly-
saccharide vaccine (PCV7) [1,2,3,4]. Non-vaccine serotypes are
emerging and some new clones have evolved by capsule switch
[5,6,7,8]. Current evolution of S. pneumoniae under vaccine
selection pressure demonstrates the plasticity of this pathogen,
but the direction and consequences of such evolution cannot be
predicted. Evolution of S. pneumoniae occurs by lateral gene transfer
in the human nasopharynx, the natural habitat of pneumococci
[9,10]. Gene transfer between pneumococcal strains likely requires
the simultaneous presence of two pneumococcal strains in the
nasopharynx also termed multiple colonization or cocolonization.
Data about the epidemiology of multiple colonization are
limited. Existing prevalence estimates range from 1.3% to 30%
[11,12,13,14,15,16,17,18]. Geographical variations in pneumo-
coccal epidemiology and different techniques employed may be
responsible for such variation. Studies on cocolonization have
been hampered by the lack of sensitive, economic and easy to
apply methods for the detection of multiple strains in nasopha-
ryngeal samples. Recently, we reported on a new molecular
method for the detection of multiple colonization [19]. In this
study we applied this technique to a large collection of
nasopharyngeal swabs (n 1120) collected before and after the
introduction of PCV7 in Switzerland in 2006. This report presents
novel information about the epidemiology, determinants and time
trends of multiple colonization with S. pneumoniae in the vaccine
era. We hypothesized that reduction of the prevalent serotypes
included in PCV7 and emergence of new serotypes may affect the
rate of cocolonization and the strains or serotypes involved in
cocolonization.
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Materials and Methods
Ethic statement
Nasopharyngeal swabs used for this study were collected within
a nationwide surveillance program from outpatients with acute
otitis media or pneumonia, which is ongoing since 1998 [20,21].
This surveillance program is part of the governmental public
health surveillance and is therefore exempted from approval by
Institutional Review Boards.
Collection of nasopharyngeal swabs
For this study swabs from four winter seasons between 2004 and
2009 were analyzed. Period 1 spanned from December 2004 to
February 2005, period 2 from November 2006 to March 2007,
period 3 from November 2007 to March 2008 and period 4 from
November 2008 to March 2009. Parts of the data from period 1
have been presented earlier [19]. In Switzerland, the seven-valent
conjugated pneumococcal polysaccharide vaccine (PCV7) has
been recommended since May 2006 to all children under the age
of 24 months in a three dose schedule given at 2, 4 and 12 months
and since August 2006 the vaccine is reimbursed by health
insurance.
Diagnostic work-up of nasopharyngeal swabs
Processing of swabs for culture and capsular serotyping of S.
pneumoniae and for direct molecular detection of pneumococcal
cocolonization by plyNCR PCR and subsequent restriction
fragment length polymorphism (plyNCR RFLP) and terminal-
RFLP (T-RFLP) has been described in detail previously [19,22].
Briefly, swabs were streaked out onto a CSBA (Columbia sheep
blood agar) plates and were then eluted in 800 ml of either
transport medium for chlamydia and viruses (TMCV, [19]) or in
water. The swab solution was stored at 280uC until further use.
All pneumococcal isolates detected by primary conventional
culture were subcultured once on CSBA plates and stored at
280uC (ProtectH, Technical Service, Lancashire, UK). In
addition, during study period 4 the entire bacterial lawn grown
on the primary CSBA culture plate was collected and stored at
280uC (ProtectH, Technical Service, Lancashire, UK).
Detection of pneumococcal colonization and multiple
colonization by plyNCR PCR, RFLP and T-RFLP
Chromosomal bacterial DNA was isolated from stored swab
solution and plyNCR PCR was performed as described previously
[19]. In order to estimate the amount of pneumococcal DNA in
swab samples as a surrogate for colonization density chromosomal
DNA of three clinical isolate of S. pneumoniae (strain B109.48 of
serotype 9V, strain 109.24 of serotype 19F, strain 312.57 of
serotype 3) was isolated [23] and DNA concentration was
determined with a Nanodrop ND-100 spectrophotometer (Nano-
drop Technologies, Wilmington, DE). DNA was then diluted with
double distilled water to amounts of 100, 10, 1, 0.1, 0.01 and
0.001 ng. After plyNCR PCR amplification DNA concentration
was determined using the Agilent 2100 bioanalyzer (Agilent
Technologies, Palo Alto, CA). A standard curve was generated by
plotting PCR-product concentration against amount of DNA.
This showed a linear relationship for the range of bacterial DNA
concentrations usually found in nasopharyngeal swabs (data not
shown). plyNCR RFLP analysis was performed as described in [19]
and samples for which the sum of the size of the bands obtained
after restriction enzyme digestion was greater than the size of the
undigested PCR product were further analyzed for cocolonization.
In order to confirm the presence or absence of S. pneumoniae in
samples with plyNCR PCR products of atypical band size or .1
band, PCR for psaA was performed as described [19,24].
T-RFLP analysis was used to determine the number of strains
and their relative quantity in cocolonized samples as described
except that capillary electrophoresis was performed on an ABI
Genetic Analyzer 3130 for samples in time periods 2 to 4 [19]. In
addition, T-RFLP with the two enzymes BtsCI and Bsu36I was
used to detect cocolonization in samples with low pneumococcal
DNA content.
Detection of capsular serotypes
Capsular serotypes were determined for cultured isolates by the
‘‘agglutination reaction’’ (Statens Serum Institute, Copenhagen,
Denmark). Multiplex PCR and microarray were employed for
molecular detection of serotypes in cocolonized samples. Both
techniques are usually not performed directly on swab material,
due to lower sensitivity and requirement of large amounts of swab
material. Therefore, we used frozen stocks from primary culture
isolates and frozen stocks from bacterial lawns from the primary
culture plate for these tests. Multiplex PCR for 29 capsular
serotypes/serogroups was performed according to the method
described by Pai et al. [25] (except that PCR analysis was
performed with the Agilent bioanalyzer). Molecular serotyping by
microarray was performed using the BmG@S SP-CPSv1.3.0
microarray using standard protocols. Briefly, DNA samples were
fluorescently labelled and hybridized to the Agilent 8615K format
microarray according to manufacturer’s instructions for the
Agilent genomic DNA enzymatic labelling and oligo aCGH
hybridisation reagent kits. Microarray data was statistically
analysed using a Bayesian hierarchical model (Newton et al.,
unpublished data) to determine the serotype, or combination of
serotypes, present in the sample and assign a relative abundance of
each serotype detected.
Statistical analysis
Statistical analysis was done in StatViewH version 5.0 (SAS
Institute Inc., Cary, NC). Differences between means were tested
by the Student’s T-test or the Mann-Whitney U test and
proportions were compared with the Chi Square or Fisher’s exact
test, as appropriate. Risk factors identified by univariate statistics
were entered into ANOVA or a logistic regression model as
appropriate. The final model contained the largest number of
variables with p #0.05. A cut-off of p #0.05, two tailed, was used
for all statistical analyses.
Results
Pneumococcal carriage rate by culture and PCR
The overall pneumococcal carriage rate was 45.8% (514 of
1120 swabs) by culture or PCR, the rate was 39.7% by bacterial
culture, and 45.6% by PCR. Sixty nine samples (6.1%) were
positive by PCR only and three samples were positive by culture
only. A total of 389 of 511 (74.3%) PCR positive samples were
screened for cocolonization by plyNCR RFLP and T-RFLP. The
remaining 122 samples could not be processed, because quantity
of DNA recovered from swabs was insufficient for enzyme
digestion (n= 83), or because plyNCR PCR amplified more than
one band (n= 40), which inhibited interpretation of restriction
enzyme patterns [19].
Pneumococcal vaccination rates
Patients were mostly children and about half of patients were below
the age of 5 years (49.0%, n 549). PCV7 vaccination rates increased
during the study period. Among children less than 5 years of age
S. pneumoniae Cocolonization
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vaccination rates were 3.2% for study period 1, 33.3% for study period
2, 50% for study period 3, and 77.8% for study period 4. The
corresponding rates for children,2 years of age for time periods 1, 2,
3, and 4 were 1.4%, 47.3%, 76.3%, and 88.4%, respectively.
Therefore, study period 1 was considered the ‘‘prevaccine era’’ and
the later seasons combined were defined as the ‘‘vaccine era’’.
Figure 1. Ratio of strains present in cocolonized nasopharyngeal swabs. Strain ratios were determined from the peak heights in the
chromatograms obtained by terminal-restriction fragment length polymorphism analysis (T-RFLP, as described in the methods section). The X-axis
indicates the fold-higher presence of the more abundant strain. The three samples with three strains were excluded.
doi:10.1371/journal.pone.0011638.g001
Table 1. Univariate analysis for factors associated with carriage of single or multiple strains of Streptococcus pneumoniae.
Cocolonization Single colonization Not colonized p
N % N % N %
Total 41 100 473 100 606 100
Introduction of PCV7a
prevaccine era 10 25.6 139 29.4 138 22.8
vaccine era 31 74.4 334 70.6 468 77.2
Age (years)b
,2 14 34.1 138 29.2 119 19.8 ,0.001
2–4 14 34.1 150 32.0 113 18.8
5–16 11 26.8 117 24.8 144 24.0
17–64 2 4.9 55 11.7 170 28.3
.64 0 0 11 2.3 54 9.0
Female gendec 17 41.5 207 44.0 286 47.6 0.43
Antibiotic treatmentd 8 20.5 55 12.9 84 15.4 0.29
Day caree in children ,5 years old 7 26.9 106 39.5 72 33.6 0.24
Recurrent otitisf media in children ,5 years old 4 15.4 55 21.2 47 22.3 0.71
PCV7 vaccinatedg in children ,5 years old 9 34.6 102 36.3 98 45.4 0.03
aPCV7 = 7-valent conjugated pneumococcal polysaccharide vaccine.
bNo information was available about age for 7 patients.
cNo information was available about gender for 4 patients.
dAntibiotic treatment during the 8 weeks before swab collection, no information was available for 108 patients (9.6%).
eNo information about current day care use was available for 152 patients (13.5%).
fMore than one otitis media episode during the past 12 months. No information was available about recurrent otitis media for 183 patients (16.3%).
gVaccination with the seven-valent conjugated pneumococcal vaccine.
No information about vaccination status was available for 100 patients (8.9%). P-value is for the comparison between carriage of single or multiple strains of S.
pneumoniae versus no carriage.
doi:10.1371/journal.pone.0011638.t001
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Detection of multiple colonization
Cocolonization was detected in 41 nasopharyngeal swabs by
RFLP or T-RFLP. Only seven of these 41 cocolonization events
were also detected by conventional serotyping of multiple (n = 20)
colonies from primary swab culture plates. Two different strains
were present in 38 of the 41 samples and three samples contained
three strains. The relative ratio of strains present in the same
sample ranged from 1:1 to a maximum of 1:45, with a median
ratio of 1:3.8 (Figure 1).
Frequency of multiple colonization
The rate of cocolonization was 3.6% among all samples (n 1120)
and 7.9% among samples with detection of S. pneumoniae (n 514).
The rate of cocolonization was similar before and after
introduction of PCV7 with a prevaccine rate of 3.4% (10 of 287
samples) or 6.7% (10 of 149 samples with detection of S.
pneumoniae) as compared to 3.7% (31 of 833 samples) or 8.4%
(31 of 365 samples with detection of S. pneumoniae) after
introduction of PCV7. Cocolonization rates were also stable over
the four time periods analysed (data not shown).
Factors associated with multiple colonization
Cocolonization was more frequent at younger age (Table 1).
The probability of cocolonization was not affected by recent
antibiotic treatment, day care use, a history of recurrent acute
otitis media or PCV7 vaccination status. However, pneumococcal
colonization density (the concentration of the plyNCR PCR
product) was significantly higher in samples with multiple
colonization (p,0.001) (Table 2).
Multiple colonization and plyNCR RFLP-types
We have previously shown that plyNCR RFLP can be used for
molecular typing of pneumococcal strains [22]. We were interested
to analyze whether strains involved in cocolonization belonged to
distinct RFLPtypes. A RFLP-type could be determined for 81 of
the 85 pneumococcal strains present in samples with multiple
colonization. The 81 strains grouped into 30 different RFLP types,
of which 13 occurred at a relative frequency of $2% relative to all
RFLP types detected in this study. The remaining RFLP types
with a prevalence of ,2% were designated ‘‘rare’’ and were
grouped together into the category ‘‘others’’ for analysis. RFLP
type 15 (p 0.01), type 17 (p 0.02), and type 19 (p 0.03) were
significantly more frequent among cocolonized samples, and
samples with only one strain had a higher proportion of type 2 (p
0.02) and type 11 (p 0.01). There were no time trends of RFLP
type distribution between the prevaccine and vaccine era (data not
shown). Pairs of RFLP types in cocolonized samples showed no
predominance of a certain combination of RFLP-types (data not
shown).
Multiple colonization and capsular serotypes
A serotype could be determined for 64 of 85 strains detected in
the 41 cocolonized samples. The 64 strains grouped into 30
different serotypes and non-typeable pneumococci. Serotypes with
Table 2. Univariate analysis of DNA quantity of plyNCR PCR products as a surrogate for pneumococcal colonization density in the
nasopharynx.
DNA concentration of PCR product
ng/ml Proportion of samples with ,10 ng/ml
mean SD p N % p
All 26.6 20.2 149 31.7
Age (years)a 0.07 0.03
,2 29.1 20.5 37 24.5
2–4 27.2 19.4 44 26.9
$5 24.3 20.5 68 34.8
Gender 0.02 0.04
Female 29.0 20.3 54 24.2
Male 25.0 19.9 92 32.2
PCV7 vaccinatedb, ,2 years olds 0.06 0.08c
yes 26.1 20.0 22 30.9
no 32.4 20.8 14 18.6
Cocolonization 0.003 ,0.001
yes 35.3 16.5 0 0
no 25.9 20.3 149 31.7
PCV7 serotyped, ,2 years olds 0.20 0.92
yes 38.0 19.0 5 12.1
no 32.6 19.9 7 16.2
aNo information was available about age for 7 patients.
bPCV7 = seven-valent conjugated pneumococcal vaccine.
cThis associations became statistically significant after adjustment for carriage of a serotype contained in PCV7 in a logistic regression model (p = 0.02).
dCarriage of a serotype contained in the seven-valent conjugated pneumococcal vaccine; i.e. one of the following serotypes: 4, 6B, 9V, 14, 18C, 19F.
No information about vaccination status was available for 100 patients (8.9%). P-values compare the carriage of single or multiple strains of S. pneumoniae to no
carriage.
doi:10.1371/journal.pone.0011638.t002
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a relative frequency of less than 2% were designated ‘‘rare’’ and
grouped together as ‘‘other serotypes’’ for analysis. These rare
serotypes/-groups included 1, 8, 9 (except 9V), 10, 16, 17, 17F, 18
(except 18C), 20, 21, 28, 33, 34, 35, 38 and non-typeable isolates.
Interestingly, in cocolonized samples rare serotypes were more
frequently represented than the prevalent serotypes (23.4% versus
11.4%. p= 0.01) (Figure 2A). Also, non-typeable pneumococci
were detected more often in cocolonized samples than in those
with a single strain (4.7% versus 0.5%, Fisher’s exact test p= 0.02)
(Figure 2B).
Time trends of serotype distribution between the prevaccine
and vaccine era were comparable among samples with single or
multiple colonization except that the proportion of rare serotypes
increased among samples with multiple colonization in the vaccine
era (Figure 3).
Pairs of serotypes in cocolonized samples showed no predom-
inance of a certain combination of serotypes, but none of the
cocolonized samples showed a combination of serotypes included
in PCV7 (data not shown).
Discussion
Simultaneous colonization of the human nasopharynx with
more than one strain or serotype of S. pneumoniae is an intriguing
event. It sets the stage for pneumococcal evolution through
horizontal exchange of genes, which may result in the acquisition
of antibiotic resistance or capsule switch [9]. In addition, the study
of cocolonization offers insight into the interaction between
different strains or serotypes of S. pneumoniae. This study shows
that PCV7 selection pressure did not affect the cocolonization rate
up to three years after the introduction of the vaccine. Therefore,
opportunities for horizontal gene transfer between pneumococci in
the nasopharynx will continue to occur at the same frequency in
the vaccine era as in the prevaccine era and new strains may
emerge under vaccine selection pressure as has been described [5].
One might have expected that cocolonization would involve
more frequently the prevalent serotypes with high incidence of
acquisition and long duration of carriage [21,26,27]. However, in
this study, rare serotypes predominated among cocolonizing
Figure 2. Serotype distribution among nasopharyngeal S. pneumoniae isolates. A. Serotype distribution among nasopharyngeal isolates (n
468) of S. pneumoniae stratified according to the detection of cocolonization or single colonization with S. pneumoniae strains. The group
‘‘cocolonizing’’ includes the 64 isolates from cocolonized samples, for which a serotype could be determined. Serotypes with a relative frequency of
less than 2% are summarized as ‘‘others’’. They included serotypes/-groups 1, 8, 9 (except 9V), 10, 16, 17, 17F, 18 (except 18C), 20, 21, 28, 33, 34, 35, 38
and non-typeable isolates. The rate of rare serotypes (‘‘others’’) was significantly higher in cocolonized than in single colonized swabs (23.4% vs.
11.4%, p= 0.01), but difference in the frequency of individual serotypes (for example for the serotypes 11, 15, and 19F) did not reach statistical
significance. B. Distribution of rare serotypes (group ‘‘other’’ in Figure 2A) in samples with or without cocolonization. The difference between the
proportion of non-typeable strains in cocolonized samples (4.7%) and in those with a single strain (0.5%) was statistically significant (Fisher’s exact
test p = 0.02).
doi:10.1371/journal.pone.0011638.g002
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pneumococcal strains. For example, serotype 19F, one of the most
carried serotypes, was relatively rare among cocolonizing strains
already in the prevaccine era and serotype 19A did not emerge
among cocolonizing strains in the vaccine era as it did among
single colonizing strains. The observed predominance of rare
serotypes during cocolonization suggests that simultaneous
colonization is not simply a consequence of cumulative exposure
to transmission opportunities. This hypothesis is also supported by
the observed lack of an association of cocolonization with day care
usage, a history of recurrent otitis media and recent antibiotic
exposure.
It has been shown that pneumococcal serotypes differ for their
competitiveness in colonizing the nasopharynx [28]; some
serotypes, such as 6B can outcompete others, such as 23F. In
our study, colonization density was significantly higher in
nasopharyngeal swabs containing multiple pneumococcal strains
as compared to those swabs with a single strain. Also, the median
ratio of two pneumococcal strains in a given sample was balanced
(median 1.3). Therefore, cocolonizing strains seem to co-exist
rather than to compete with each other for example for resources
(i.e. nutrients, space) or by production of bacteriocins. Margolis
and colleagues recently showed in a rat colonization study that
sequential cocolonization with two pneumococcal strains can lead
to stable co-existence and a higher density for cocolonization
compared to single colonization [29]. Whether the tendency for
co-existence between some pneumococcal serotypes, as described
here, may also apply to co-existence with other pathogens such as
H. influenzae and S. aureus needs to be studied [30,31,32,33].
Serotypes, which predominated in multiple colonization in this
study, did not include serotypes covered by the seven-, ten- or
thirteen-valent conjugated polysaccharide vaccines, and the
prevalence of these rare serotypes increased in the vaccine era
Figure 3. Relative distribution of pneumococcal serotypes among 468 pneumococcal strains isolated in prevaccine or vaccine era.
The relative frequency of pneumococcal serotypes isolated from nasopharyngeal swabs before and after the introduction of the seven-valent
conjugated polysaccharide vaccine for (A) swabs with one serotype only (prevaccine era n 106, vaccine era n 298), and (B) restricted to isolates from
cocolonized samples (prevaccine era n 12, vaccine era n 52). For easier reading of the graph rare serotypes (prevalence ,2%) were grouped as
‘‘others’’. They included serotypes and/or serogroups 1, 8, 9 (except 9V), 10, 16, 17, 17F, 18 (except 18C), 20, 21, 28, 33, 34, 35, 38 and non-typeable
isolates.
doi:10.1371/journal.pone.0011638.g003
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(Figure 3). Therefore, we can not exclude that rates of multiple
colonization may increase in the future with the emergence of
these serotypes. The follow-up period of three years after
introduction of PCV7 may have been too short to observe such
a trend.
A limitation of this study is that the study population was
restricted to patients with acute otitis media or pneumonia. The
conclusions drawn from this study may therefore not apply to
healthy persons. Also, the epidemiology of cocolonization may be
different in populations with overall higher carriage rates than
observed in our study [11,17,34]. Multiplex PCR for the detection
of pneumococcal serotypes has also been used for the detection of
cocolonization [11]. Whilst multiplex PCR for serotype cannot
detect cocolonization by different pneumococcal strains of the
same serotype the method used in this study, plyNCR RFLP and T-
RFLP, will miss cocolonization by two serotypes with an identical
RFLP type. We compared the performance of multiplex PCR and
T-/RFLP for the detection of cocolonization in 141 consecutive
nasopharyngeal swabs (from time period 4) and found a slightly
higher sensitivity for the T-/RFLP assay than multiplex PCR:
cocolonization was detected by both methods in six samples, by
T-/RFLP only in 8 samples, and by multiplex PCR only in one
sample (Table 3). Therefore, we believe that this study did not
underestimate the cocolonization rate in comparison to studies
using multiplex PCR.
In summary, this study showed that pneumococcal cocoloniza-
tion rates have not been affected by the selection pressure of PCV
up to 3 years after the introduction of universal vaccination.
Multiple colonization involves more often serotypes that have been
of low prevalence in the prevaccine era, but may now emerge
under vaccine selection pressure. This may lead to an increase in
the cocolonization rate in the future, with an increasing
opportunity for pneumococcal evolution through horizontal gene
exchange.
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